Outcomes after Re-Irradiation of an IDH Wild-type Glioblastoma Cohort

被引:0
|
作者
Wolfgang, Josy [1 ]
Ehret, Felix [1 ]
Allwohn, Luisa [1 ]
Roohani, Siyer [1 ]
Oertel, Joachim [2 ]
Zips, Daniel [1 ]
Kaul, David [1 ]
机构
[1] Charite Univ Med Berlin, Klin Radioonkol & Strahlentherapie, Berlin, Germany
[2] Univ Saarland, Klin Neurochirurg, Homburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P05-2-jD
引用
收藏
页码:S79 / S80
页数:2
相关论文
共 50 条
  • [1] Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation
    Ehret, Felix
    Wolfgang, Josy
    Allwohn, Luisa
    Onken, Julia
    Wasilewski, David
    Roohani, Siyer
    Oertel, Joachim
    Zips, Daniel
    Kaul, David
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 42
  • [2] Prediction model of IDH wild-type glioblastoma Response
    Mijderwijk, Hendrik-Jan
    Nieboer, Daan
    Steyerberg, Ewout W.
    van den Bent, Martin J.
    Reifenberger, Guido
    Haenggi, Daniel
    Kamp, Marcel A.
    JOURNAL OF NEUROSURGERY, 2022, 137 (04) : 1200 - 1201
  • [3] Outcome after re-irradiation for recurrent glioblastoma
    Zwirner, K.
    Paulsen, F.
    Henke, G.
    Braun, C.
    Skardelly, M.
    Zips, D.
    Eckert, F.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S10 - S10
  • [4] WILD-TYPE IDH1 INHIBITS FERROPTOSIS IN GLIOBLASTOMA
    Dunterman, Madeline
    Korimerla, Navyateja
    Murnan, Kevin
    Tommasini-Ghelfi, Serena
    Wahl, Daniel
    Stegh, Alexander
    NEURO-ONCOLOGY, 2024, 26
  • [5] MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes
    Roux, Alexandre
    Roca, Pauline
    Edjlali, Myriam
    Sato, Kanako
    Zanello, Marc
    Dezamis, Edouard
    Gori, Pietro
    Lion, Stephanie
    Fleury, Ariane
    Dhermain, Frederic
    Meder, Jean-Francois
    Chretien, Fabrice
    Lechapt, Emmanuele
    Varlet, Pascale
    Oppenheim, Catherine
    Pallud, Johan
    RADIOLOGY, 2019, 293 (03) : 633 - 643
  • [6] IDH Wild-type Glioblastoma Presenting with Seizure: Clinical Specificity, and Oncologic and Surgical Outcomes.
    Pesce, Alessandro
    Armocida, Daniele
    Paglia, Francesco
    Palmieri, Mauro
    Frati, Alessandro
    D'Andrea, Giancarlo
    Salvati, Maurizio
    Santoro, Antonio
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2022, 83 (04) : 351 - 360
  • [7] The mutational landscape of older patients with IDH wild-type glioblastoma (GBM).
    Johnson, Margaret O.
    Xiu, Joanne
    Glantz, Michael J.
    Zeng, Jia
    Chen, Clark C.
    Dunbar, Erin M.
    Fonkem, Ekokobe
    Kesari, Santosh
    Brenner, Andrew J.
    Newton, Herbert B.
    Low, Justin
    Sumrall, Ashley Love
    Korn, Wolfgang Michael
    Ashley, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
    Christ, Sebastian M.
    Youssef, Gilbert
    Tanguturi, Shyam K.
    Cagney, Daniel
    Shi, Diana
    McFaline-Figueroa, J. Ricardo
    Chukwueke, Ugonma
    Lee, Eudocia Q.
    Hertler, Caroline
    Andratschke, Nicolaus
    Weller, Michael
    Reardon, David A.
    Haas-Kogan, Daphne
    Guckenberger, Matthias
    Wen, Patrick Y.
    Rahman, Rifaquat
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 44
  • [9] Prognostic parameters and outcome after re-irradiation for progressive glioblastoma
    Zwirner, K.
    Paulsen, F.
    Schittenhelm, J.
    Borchers, C.
    Skardelly, M.
    Zips, D.
    Eckert, F.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (03): : 239 - 245
  • [10] Re-irradiation of recurrent glioblastoma: a report of a single-centre cohort
    Mack, F.
    Steffens, R.
    Herrlinger, U.
    Kuhn, M.
    Glas, M.
    Baumert, B.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S101 - S102